INCANNEX HEALTHCARE LIMITED - Announcements

0.00%

4.1¢

Currently unlisted.

Incannex Healthcare Limited is an Australia-based clinical-stage pharmaceutical... Incannex Healthcare Limited is an Australia-based clinical-stage pharmaceutical development company. The Company is focused on developing medicinal cannabis pharmaceutical products and psychedelic medicine therapies for the treatment of generalized anxiety disorder (GAD), obstructive sleep apnea (OSA), traumatic brain injury (TBI)/concussion, lung inflammation, rheumatoid arthritis and inflammatory bowel disease. Its drug candidates include IHL-42X, IHL-216A and HL-675A. Its IHL-42X is a combination of acetazolamide and dronabinol for treatment of OSA. Its IHL-216A is a combination of isoflurane and cannabidiol (CBD) to prevent development of TBI/concussion. Its HL-675A comprises a combination of hydroxychloroquine and CBD for prevention and treatment of inflammatory lung conditions, rheumatoid arthritis and inflammatory bowel diseases. It is also investigating the use of psilocybin assisted psychotherapy to treat GAD.More

NATURAL MEDICINE LEADERS

The Calmer Co (ASX:CCO) FY25 Revenue Hits $8M, Up 86% on FY24

Announcements

Filter Results

All Price Sensitive Only

IHL	Notification regarding unquoted securities - IHL		12/08/22	29.8KB	Share
IHL	Application for quotation of securities - IHL		12/08/22	24.83KB	Share
IHL	Notification regarding unquoted securities - IHL		12/08/22	25.89KB	Share
IHL	Application for quotation of securities - IHL		12/08/22	24.84KB	Share
IHL	Incannex Healthcare Company Overview	PRICE SENSITIVE	09/08/22	3.57MB	Share
IHL	Notification regarding unquoted securities - IHL		09/08/22	25.81KB	Share
IHL	Application for quotation of securities - IHL		09/08/22	27.07KB	Share
IHL	Incannex Completes Acquisition of APIRx	PRICE SENSITIVE	05/08/22	143.5KB	Share
IHL	Proposed issue of securities - IHL		05/08/22	37.3KB	Share
IHL	IHL Engages Curia to Scale-up Manufacture of cGMP IHL-216A	PRICE SENSITIVE	02/08/22	165.93KB	Share
IHL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	27/07/22	401.06KB	Share
IHL	Ethics Approval Received to start Ph 1 Clinical of IHL 675A	PRICE SENSITIVE	21/07/22	226.72KB	Share
IHL	Change of Auditor		07/07/22	59.08KB	Share
IHL	Cleansing Notice		05/07/22	67.27KB	Share
IHL	Director's Initial and Final Interest Notice		29/06/22	351.63KB	Share
IHL	Application for quotation of securities - IHL		29/06/22	24.78KB	Share
IHL	Notification regarding unquoted securities - IHL		28/06/22	24.77KB	Share
IHL	Proposed issue of securities - IHL		28/06/22	46.71KB	Share
IHL	Director and management update		28/06/22	151.89KB	Share
IHL	Incannex to Present at the H.C. Wainwright Conferecne		27/06/22	132.03KB	Share
IHL	Notification regarding unquoted securities - IHL		17/06/22	27.08KB	Share
IHL	Application for quotation of securities - IHL		17/06/22	27.71KB	Share
IHL	Appendix 2A and 3G, Cleansing Notice		17/06/22	123.72KB	Share
IHL	Results of Meeting		09/06/22	95.67KB	Share
IHL	IHL-42X phase 2 clinical trial presentation	PRICE SENSITIVE	03/06/22	6.58MB	Share
IHL	Positive final results from IHL-42X phase 2 trial	PRICE SENSITIVE	03/06/22	217.48KB	Share
IHL	Correction to Notice of General Meeting		03/06/22	120.81KB	Share
IHL	Positive FDA Pre-IND meeting guides IHL-42X development	PRICE SENSITIVE	17/05/22	145.8KB	Share
IHL	APIRx Acquisition Presentation	PRICE SENSITIVE	12/05/22	4.43MB	Share
IHL	Incannex completes APIRx Share Sale and Purchase Agreement	PRICE SENSITIVE	12/05/22	143.63KB	Share
IHL	Notice of General Meeting/Proxy Form		12/05/22	1.11MB	Share
IHL	IHL-216A Preclinical Study Results	PRICE SENSITIVE	10/05/22	468.59KB	Share
IHL	Trading Halt	PRICE SENSITIVE	06/05/22	200.22KB	Share
IHL	Application for quotation of securities - IHL		05/05/22	24.78KB	Share
IHL	Proposed issue of securities - IHL		03/05/22	24.49KB	Share
IHL	Appendix 2A		02/05/22	376.09KB	Share
IHL	Proposed issue of securities - IHL		29/04/22	35.29KB	Share
IHL	March Quarterly Activities Report and App 4C	PRICE SENSITIVE	28/04/22	421.36KB	Share
IHL	Loyalty Option Issue Raises $23.6M	PRICE SENSITIVE	28/04/22	147.28KB	Share
IHL	Appendix 3G		31/03/22	325.34KB	Share
IHL	Loyalty Options Prospectus	PRICE SENSITIVE	29/03/22	468.27KB	Share
IHL	Incannex to Acquire APIRx Pharmaceuticals	PRICE SENSITIVE	24/03/22	331.38KB	Share
IHL	Trading Halt	PRICE SENSITIVE	22/03/22	198.45KB	Share
IHL	Pause in Trading	PRICE SENSITIVE	22/03/22	115.48KB	Share
IHL	Appendix 3B - Amended		22/03/22	722.52KB	Share
IHL	Loyalty Options - Amended Timetable		21/03/22	152.64KB	Share
IHL	Appendix 3B		21/03/22	722.63KB	Share
IHL	Incannex to Issue Loyalty Options to Shareholders	PRICE SENSITIVE	18/03/22	166.55KB	Share
IHL	Cleansing Notice		16/03/22	86.85KB	Share
IHL	Appendix 2A		16/03/22	92.28KB	Share
IHL	IHL-42X positive phase 2 clinical trial results	PRICE SENSITIVE	10/03/22	170.63KB	Share
IHL	Trading Halt	PRICE SENSITIVE	08/03/22	200.78KB	Share
IHL	S&P DJI Announces March 2022 Quarterly Rebalance	PRICE SENSITIVE	04/03/22	175.5KB	Share
IHL	IHL - VR and psychedelic R&D program	PRICE SENSITIVE	03/03/22	174.95KB	Share
IHL	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/22	845.77KB	Share
IHL	Incannex Lists on Nasdaq and Rings Closing Bell	PRICE SENSITIVE	28/02/22	360.71KB	Share
IHL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/22	407.19KB	Share
IHL	Corporate Governance Statement and Appendix 4G		28/01/22	542.49KB	Share
IHL	Results of Meeting		20/01/22	94.82KB	Share
IHL	CEO Address at FY21 A G M	PRICE SENSITIVE	20/01/22	139.95KB	Share
IHL	Change of Registry Address		18/01/22	151.45KB	Share
IHL	Appendix 4G		17/01/22	274.03KB	Share
IHL	IHL-42X Phase 2 Trial Dosing Completed and pre-IND Update	PRICE SENSITIVE	20/12/21	180.81KB	Share
IHL	Notice of Annual General Meeting/Proxy Form		20/12/21	1.2MB	Share
IHL	Update on Nasdaq Listing	PRICE SENSITIVE	17/12/21	140.11KB	Share
IHL	Becoming a substantial holder		30/11/21	1.06MB	Share
IHL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/10/21	392.88KB	Share
IHL	IHL Announces - Psi-GAD PIND and Ethics Approval	PRICE SENSITIVE	28/10/21	149.16KB	Share
IHL	Jobkeeper Payments Notification		26/10/21	31.69KB	Share
IHL	Incannex engages Procaps to produce IHL-42X	PRICE SENSITIVE	20/10/21	154.56KB	Share
IHL	Becoming a substantial holder - Amended		11/10/21	88.87KB	Share
IHL	Becoming a substantial holder		08/10/21	72.93KB	Share
IHL	Appendix 3Y		07/10/21	186.72KB	Share
IHL	Application for quotation of securities - IHL		07/10/21	24.74KB	Share
IHL	Proposed issue of securities - IHL		06/10/21	24.47KB	Share
IHL	Cleansing Notice		04/10/21	88.38KB	Share
IHL	Incannex Completes Options exercise Program		04/10/21	143.37KB	Share
IHL	Application for quotation of securities - IHL		04/10/21	27.45KB	Share
IHL	Cleansing Notice		21/09/21	86.9KB	Share
IHL	Appendix 3Y x 2		21/09/21	274.19KB	Share
IHL	Application for quotation of securities - IHL		21/09/21	24.78KB	Share
IHL	Results of Meeting		17/09/21	92.76KB	Share
IHL	Appendix 4G		14/09/21	240.98KB	Share
IHL	Appendix 3Y Amended		08/09/21	187.17KB	Share
IHL	Cleansing Notice		08/09/21	87.33KB	Share
IHL	Appendix 3Y x 2		08/09/21	360.8KB	Share
IHL	Application for quotation of securities - IHL		08/09/21	27.44KB	Share
IHL	Annual Report to Shareholders		07/09/21	6.31MB	Share
IHL	Appendix 4E & Financial Report for the year ended 30 June 21	PRICE SENSITIVE	30/08/21	2.78MB	Share
IHL	Application for quotation of securities - IHL		26/08/21	24.77KB	Share
IHL	Cleansing Notice - Options Exercise		26/08/21	86.89KB	Share
IHL	Notification regarding unquoted securities - IHL		26/08/21	24.47KB	Share
IHL	Notice of General Meeting/Proxy Form		19/08/21	717.7KB	Share
IHL	IHL files Form F-1 registration statement with SEC	PRICE SENSITIVE	18/08/21	1.77MB	Share
IHL	Cleansing Notice - Options Exercise		17/08/21	86.92KB	Share
IHL	Application for quotation of securities - IHL		17/08/21	24.77KB	Share
IHL	Incannex Psychedelic Therapies Presentation	PRICE SENSITIVE	11/08/21	1.12MB	Share
IHL	HREC and FDA pre-IND request for Psilocybin Therapy	PRICE SENSITIVE	10/08/21	202.54KB	Share
IHL	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/07/21	397.86KB	Share
IHL	IHL commences IHL-675A trial and patent application	PRICE SENSITIVE	27/07/21	209.9KB	Share

IHL Notification regarding unquoted securities - IHL
12/08/22		29.8KB	Share
IHL Application for quotation of securities - IHL
12/08/22		24.83KB	Share
IHL Notification regarding unquoted securities - IHL
12/08/22		25.89KB	Share
IHL Application for quotation of securities - IHL
12/08/22		24.84KB	Share
IHL Incannex Healthcare Company Overview
09/08/22	PRICE SENSITIVE	3.57MB	Share
IHL Notification regarding unquoted securities - IHL
09/08/22		25.81KB	Share
IHL Application for quotation of securities - IHL
09/08/22		27.07KB	Share
IHL Incannex Completes Acquisition of APIRx
05/08/22	PRICE SENSITIVE	143.5KB	Share
IHL Proposed issue of securities - IHL
05/08/22		37.3KB	Share
IHL IHL Engages Curia to Scale-up Manufacture of cGMP IHL-216A
02/08/22	PRICE SENSITIVE	165.93KB	Share
IHL Quarterly Activities/Appendix 4C Cash Flow Report
27/07/22	PRICE SENSITIVE	401.06KB	Share
IHL Ethics Approval Received to start Ph 1 Clinical of IHL 675A
21/07/22	PRICE SENSITIVE	226.72KB	Share
IHL Change of Auditor
07/07/22		59.08KB	Share
IHL Cleansing Notice
05/07/22		67.27KB	Share
IHL Director's Initial and Final Interest Notice
29/06/22		351.63KB	Share
IHL Application for quotation of securities - IHL
29/06/22		24.78KB	Share
IHL Notification regarding unquoted securities - IHL
28/06/22		24.77KB	Share
IHL Proposed issue of securities - IHL
28/06/22		46.71KB	Share
IHL Director and management update
28/06/22		151.89KB	Share
IHL Incannex to Present at the H.C. Wainwright Conferecne
27/06/22		132.03KB	Share
IHL Notification regarding unquoted securities - IHL
17/06/22		27.08KB	Share
IHL Application for quotation of securities - IHL
17/06/22		27.71KB	Share
IHL Appendix 2A and 3G, Cleansing Notice
17/06/22		123.72KB	Share
IHL Results of Meeting
09/06/22		95.67KB	Share
IHL IHL-42X phase 2 clinical trial presentation
03/06/22	PRICE SENSITIVE	6.58MB	Share
IHL Positive final results from IHL-42X phase 2 trial
03/06/22	PRICE SENSITIVE	217.48KB	Share
IHL Correction to Notice of General Meeting
03/06/22		120.81KB	Share
IHL Positive FDA Pre-IND meeting guides IHL-42X development
17/05/22	PRICE SENSITIVE	145.8KB	Share
IHL APIRx Acquisition Presentation
12/05/22	PRICE SENSITIVE	4.43MB	Share
IHL Incannex completes APIRx Share Sale and Purchase Agreement
12/05/22	PRICE SENSITIVE	143.63KB	Share
IHL Notice of General Meeting/Proxy Form
12/05/22		1.11MB	Share
IHL IHL-216A Preclinical Study Results
10/05/22	PRICE SENSITIVE	468.59KB	Share
IHL Trading Halt
06/05/22	PRICE SENSITIVE	200.22KB	Share
IHL Application for quotation of securities - IHL
05/05/22		24.78KB	Share
IHL Proposed issue of securities - IHL
03/05/22		24.49KB	Share
IHL Appendix 2A
02/05/22		376.09KB	Share
IHL Proposed issue of securities - IHL
29/04/22		35.29KB	Share
IHL March Quarterly Activities Report and App 4C
28/04/22	PRICE SENSITIVE	421.36KB	Share
IHL Loyalty Option Issue Raises $23.6M
28/04/22	PRICE SENSITIVE	147.28KB	Share
IHL Appendix 3G
31/03/22		325.34KB	Share
IHL Loyalty Options Prospectus
29/03/22	PRICE SENSITIVE	468.27KB	Share
IHL Incannex to Acquire APIRx Pharmaceuticals
24/03/22	PRICE SENSITIVE	331.38KB	Share
IHL Trading Halt
22/03/22	PRICE SENSITIVE	198.45KB	Share
IHL Pause in Trading
22/03/22	PRICE SENSITIVE	115.48KB	Share
IHL Appendix 3B - Amended
22/03/22		722.52KB	Share
IHL Loyalty Options - Amended Timetable
21/03/22		152.64KB	Share
IHL Appendix 3B
21/03/22		722.63KB	Share
IHL Incannex to Issue Loyalty Options to Shareholders
18/03/22	PRICE SENSITIVE	166.55KB	Share
IHL Cleansing Notice
16/03/22		86.85KB	Share
IHL Appendix 2A
16/03/22		92.28KB	Share
IHL IHL-42X positive phase 2 clinical trial results
10/03/22	PRICE SENSITIVE	170.63KB	Share
IHL Trading Halt
08/03/22	PRICE SENSITIVE	200.78KB	Share
IHL S&P DJI Announces March 2022 Quarterly Rebalance
04/03/22	PRICE SENSITIVE	175.5KB	Share
IHL IHL - VR and psychedelic R&D program
03/03/22	PRICE SENSITIVE	174.95KB	Share
IHL Half Yearly Report and Accounts
28/02/22	PRICE SENSITIVE	845.77KB	Share
IHL Incannex Lists on Nasdaq and Rings Closing Bell
28/02/22	PRICE SENSITIVE	360.71KB	Share
IHL Quarterly Activities/Appendix 4C Cash Flow Report
31/01/22	PRICE SENSITIVE	407.19KB	Share
IHL Corporate Governance Statement and Appendix 4G
28/01/22		542.49KB	Share
IHL Results of Meeting
20/01/22		94.82KB	Share
IHL CEO Address at FY21 A G M
20/01/22	PRICE SENSITIVE	139.95KB	Share
IHL Change of Registry Address
18/01/22		151.45KB	Share
IHL Appendix 4G
17/01/22		274.03KB	Share
IHL IHL-42X Phase 2 Trial Dosing Completed and pre-IND Update
20/12/21	PRICE SENSITIVE	180.81KB	Share
IHL Notice of Annual General Meeting/Proxy Form
20/12/21		1.2MB	Share
IHL Update on Nasdaq Listing
17/12/21	PRICE SENSITIVE	140.11KB	Share
IHL Becoming a substantial holder
30/11/21		1.06MB	Share
IHL Quarterly Activities/Appendix 4C Cash Flow Report
29/10/21	PRICE SENSITIVE	392.88KB	Share
IHL IHL Announces - Psi-GAD PIND and Ethics Approval
28/10/21	PRICE SENSITIVE	149.16KB	Share
IHL Jobkeeper Payments Notification
26/10/21		31.69KB	Share
IHL Incannex engages Procaps to produce IHL-42X
20/10/21	PRICE SENSITIVE	154.56KB	Share
IHL Becoming a substantial holder - Amended
11/10/21		88.87KB	Share
IHL Becoming a substantial holder
08/10/21		72.93KB	Share
IHL Appendix 3Y
07/10/21		186.72KB	Share
IHL Application for quotation of securities - IHL
07/10/21		24.74KB	Share
IHL Proposed issue of securities - IHL
06/10/21		24.47KB	Share
IHL Cleansing Notice
04/10/21		88.38KB	Share
IHL Incannex Completes Options exercise Program
04/10/21		143.37KB	Share
IHL Application for quotation of securities - IHL
04/10/21		27.45KB	Share
IHL Cleansing Notice
21/09/21		86.9KB	Share
IHL Appendix 3Y x 2
21/09/21		274.19KB	Share
IHL Application for quotation of securities - IHL
21/09/21		24.78KB	Share
IHL Results of Meeting
17/09/21		92.76KB	Share
IHL Appendix 4G
14/09/21		240.98KB	Share
IHL Appendix 3Y Amended
08/09/21		187.17KB	Share
IHL Cleansing Notice
08/09/21		87.33KB	Share
IHL Appendix 3Y x 2
08/09/21		360.8KB	Share
IHL Application for quotation of securities - IHL
08/09/21		27.44KB	Share
IHL Annual Report to Shareholders
07/09/21		6.31MB	Share
IHL Appendix 4E & Financial Report for the year ended 30 June 21
30/08/21	PRICE SENSITIVE	2.78MB	Share
IHL Application for quotation of securities - IHL
26/08/21		24.77KB	Share
IHL Cleansing Notice - Options Exercise
26/08/21		86.89KB	Share
IHL Notification regarding unquoted securities - IHL
26/08/21		24.47KB	Share
IHL Notice of General Meeting/Proxy Form
19/08/21		717.7KB	Share
IHL IHL files Form F-1 registration statement with SEC
18/08/21	PRICE SENSITIVE	1.77MB	Share
IHL Cleansing Notice - Options Exercise
17/08/21		86.92KB	Share
IHL Application for quotation of securities - IHL
17/08/21		24.77KB	Share
IHL Incannex Psychedelic Therapies Presentation
11/08/21	PRICE SENSITIVE	1.12MB	Share
IHL HREC and FDA pre-IND request for Psilocybin Therapy
10/08/21	PRICE SENSITIVE	202.54KB	Share
IHL Quarterly Activities/Appendix 4C Cash Flow Report
30/07/21	PRICE SENSITIVE	397.86KB	Share
IHL IHL commences IHL-675A trial and patent application
27/07/21	PRICE SENSITIVE	209.9KB	Share

REFRESH

First 2 3 4 5

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

INCANNEX HEALTHCARE LIMITED - Announcements

Announcements

Top Stories